BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 12374430)

  • 1. Cellular replacement therapy for Parkinson's disease--where we are today?
    Redmond DE
    Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.
    Barker RA; Barrett J; Mason SL; Björklund A
    Lancet Neurol; 2013 Jan; 12(1):84-91. PubMed ID: 23237903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.
    Vinuela A; Hallett PJ; Reske-Nielsen C; Patterson M; Sotnikova TD; Caron MG; Gainetdinov RR; Isacson O
    Brain; 2008 Dec; 131(Pt 12):3361-79. PubMed ID: 18988638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
    Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
    Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
    Barker RA; Kuan WL
    Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplants in Parkinson's disease.
    Lindvall O
    Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation therapy for Parkinson's disease.
    Borlongan CV
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple target neural transplantation strategy for Parkinson's disease.
    Ramachandran AC; Bartlett LE; Mendez IM
    Rev Neurosci; 2002; 13(3):243-56. PubMed ID: 12405227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell replacement strategies for neurodegenerative disorders.
    Björklund A
    Novartis Found Symp; 2000; 231():7-15; discussion 16-20. PubMed ID: 11131546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural transplantation for the treatment of Parkinson's disease.
    Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
    Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
    [No Abstract]   [Full Text] [Related]  

  • 12. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
    Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
    J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
    Sautter J; Kupsch A; Oertel WH; Earl CD
    Zentralbl Neurochir; 1995; 56(4):161-7. PubMed ID: 8571694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional integration of neural grafts in Parkinson's disease.
    Barker RA; Dunnett SB
    Nat Neurosci; 1999 Dec; 2(12):1047-8. PubMed ID: 10570477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.
    Carlsson T; Carta M; Winkler C; Björklund A; Kirik D
    J Neurosci; 2007 Jul; 27(30):8011-22. PubMed ID: 17652591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 17. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
    Subrt O; Tichy M; Vladyka V; Hurt K
    Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal cell replacement in Parkinson's disease.
    Hedlund E; Perlmann T
    J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of fetal nigra transplants for Parkinson's disease.
    Kordower JH; Sortwell CE
    Prog Brain Res; 2000; 127():333-44. PubMed ID: 11142034
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of cell therapies in the treatment of Parkinson's disease.
    Laguna Goya R; Kuan WL; Barker RA
    Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.